AU5605894A - Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design - Google Patents
Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding designInfo
- Publication number
- AU5605894A AU5605894A AU56058/94A AU5605894A AU5605894A AU 5605894 A AU5605894 A AU 5605894A AU 56058/94 A AU56058/94 A AU 56058/94A AU 5605894 A AU5605894 A AU 5605894A AU 5605894 A AU5605894 A AU 5605894A
- Authority
- AU
- Australia
- Prior art keywords
- based carriers
- drug delivery
- binding design
- lipophilic peptide
- rational
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3526—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Birds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97546592A | 1992-11-12 | 1992-11-12 | |
US975465 | 1992-11-12 | ||
PCT/US1993/011021 WO1994011015A1 (en) | 1992-11-12 | 1993-11-12 | Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5605894A true AU5605894A (en) | 1994-06-08 |
Family
ID=25523057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU56058/94A Abandoned AU5605894A (en) | 1992-11-12 | 1993-11-12 | Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0670728A4 (de) |
AU (1) | AU5605894A (de) |
WO (1) | WO1994011015A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0786247B1 (de) * | 1994-11-10 | 2005-08-17 | Kanebo Cosmetics Inc. | Riechstoff mit verzögerter freisetzung und verfahren zum aufspüren von mikroorganismen unter dessen verwendung |
DE19712718C2 (de) * | 1997-03-26 | 1999-09-23 | Asta Medica Ag | Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung |
DE69704269T2 (de) * | 1997-06-11 | 2001-11-22 | School Of Pharmacy, University Of London | Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung |
CN1264310A (zh) * | 1997-07-25 | 2000-08-23 | Sdg有限公司 | 靶向传递生物活性剂的基于聚合物的药物组合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4289872A (en) * | 1979-04-06 | 1981-09-15 | Allied Corporation | Macromolecular highly branched homogeneous compound based on lysine units |
US5229490A (en) * | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
EP0339695A3 (de) * | 1988-04-29 | 1990-05-30 | Stichting Voor De Technische Wetenschappen | Verfahren zur Herstellung eines antigenen bzw. immunogenen Konjugats sowie die Verwendung solcher Konjugate |
US5252713A (en) * | 1988-09-23 | 1993-10-12 | Neorx Corporation | Polymeric carriers for non-covalent drug conjugation |
GB9107434D0 (en) * | 1991-04-09 | 1991-05-22 | Medical Res Council | Peptide-based assay |
AU671450B2 (en) * | 1992-03-20 | 1996-08-29 | Baylor College Of Medicine | A DNA transporter system and method of use |
GB9215780D0 (en) * | 1992-07-24 | 1992-09-09 | Univ London Pharmacy | Peptide compounds |
IL108388A0 (en) * | 1993-01-21 | 1994-04-12 | Harvard College | Amplified direction of effector groups to specific target cells in an animal |
WO1995000540A1 (en) * | 1993-06-18 | 1995-01-05 | Robert Webber | Synthetic carrier and immunogen |
-
1993
- 1993-11-12 EP EP94901482A patent/EP0670728A4/de not_active Withdrawn
- 1993-11-12 AU AU56058/94A patent/AU5605894A/en not_active Abandoned
- 1993-11-12 WO PCT/US1993/011021 patent/WO1994011015A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0670728A1 (de) | 1995-09-13 |
WO1994011015A1 (en) | 1994-05-26 |
EP0670728A4 (de) | 1996-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL110588A0 (en) | Bioadhesive emulsion preparations for enhanced drug delivery | |
GB2303064B (en) | Medicament for nasal administration | |
IL117728A (en) | Pharmaceutical compositions for transdermal administration comprising an active principle a promotor and a solvent | |
HU9502933D0 (en) | Pharmaceutical composition containing lipophilic drugs | |
IL109661A0 (en) | Drug delivery device | |
AU4989993A (en) | Drug delivery system | |
AU3275089A (en) | Transdermal drug delivery device | |
IL124804A0 (en) | Drug delivery device | |
GB2265088B (en) | Electrochemical device for drug delivery | |
IL180450A0 (en) | Pharmaceutical formulations comprising a waterinsoluble complex for sustained drug delivery | |
AU6534894A (en) | Drug administration system | |
AU4449789A (en) | Delivery system for pharmaceutical or therapeutic actives | |
AU4809596A (en) | Nanosuspensions for intravenous administration | |
HUP9802603A3 (en) | Lipophilic peptide hormone derivatives | |
GB9814501D0 (en) | Medication dosage reminder device | |
FI950766A0 (fi) | Painettu anostelulaite ihon kautta tapahtuvaan lääkkeen annosteluun | |
AU7454698A (en) | Improvement in medicament administration system | |
AU6461090A (en) | Injectable formulation for lipophilic drugs | |
IL116912A0 (en) | Novel pharmaceutical combination for topical administration | |
IL113793A (en) | Transdermal delivery system comprising tiagabine for anti-epileptic drugs | |
AU5605894A (en) | Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design | |
IL116910A0 (en) | Novel pharmaceutical formulation for topical administration | |
IL126855A0 (en) | Sulfonamide-substituted benzopyran derivatives processes for their preparation their use as a medicament and pharmaceutical preparations comprising them | |
AU8614291A (en) | Device for administering drugs | |
GB9325330D0 (en) | Fluorocyclodextrin drug delivery system |